Interestingly, low platelet counts have also been found as a risk factor for VTE in glioma,6 and platelet counts of patients with podoplanin‐expressing tumours were found to be decreased, suggesting that platelets are consumed in patients with podoplanin‐expressing tumours due to continuous activation. The gene discussed is PDPN; the disease is central nervous system cancer.